This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Kaiser Permanente Research Bank | |
|---|---|
| Name | Kaiser Permanente Research Bank |
| Type | Biobanking cohort |
| Founded | 2015 |
| Headquarters | Oakland, California |
| Area served | United States |
| Key people | CEO, Chief Scientific Officer |
| Parent organization | Kaiser Permanente |
Kaiser Permanente Research Bank is a large biobank and longitudinal cohort program established to support biomedical, clinical, and public health research across diverse populations in the United States. The program collects electronic health records, biospecimens, and survey data from consenting members to enable studies in genomics, epidemiology, and health services research. It serves as a resource for investigators affiliated with academic institutions, nonprofit organizations, and healthcare systems to investigate disease etiology, prevention, and treatment.
The Research Bank operates within the integrated care environment of Kaiser Permanente and links clinical data from electronic health records with banked biospecimens to support studies in genomics, epidemiology, precision medicine, pharmacogenomics, and health disparities. It enrolls adult members across multiple geographic regions, enabling comparisons across populations represented in regions such as Northern California, Southern California, Colorado, Oregon, and Washington (state). The biobank infrastructure is designed to enable investigators from institutions like Stanford University, University of California, San Francisco, Harvard University, Johns Hopkins University, and other research centers to access deidentified data under governance policies.
Founded in the mid-2010s, the initiative drew on earlier biobanking efforts such as UK Biobank, All of Us Research Program, and academic biorepositories at Broad Institute and Agilent Technologies-partnered centers. Development involved partnerships with academic medical centers including Kaiser Permanente Northern California Division of Research and external funders and advisors from institutions like National Institutes of Health and foundations associated with Bill & Melinda Gates Foundation-style philanthropy. The program scaled enrollment and specimen processing over several years, integrating lessons from cohorts like Framingham Heart Study, Nurses’ Health Study, and disease-specific consortia such as CARDIoGRAM.
Governance includes institutional review processes modeled on structures used by Institutional Review Board systems at academic centers like University of Washington and overseen by data access committees similar to those at European Bioinformatics Institute and dbGaP-linked programs. Funding sources have included internal reinvestment by Kaiser Foundation Health Plan, grants from agencies like National Human Genome Research Institute, and collaborations with nonprofit funders comparable to Robert Wood Johnson Foundation. Policies align with regulatory frameworks such as statutes managed by Food and Drug Administration and research norms influenced by reports from National Academies of Sciences, Engineering, and Medicine.
Enrollment emphasizes longitudinal follow-up of adult members with consent for recontact, linking to outcomes captured in EHR systems used across regions like Oakland, California and Portland, Oregon. Cohorts reflect diversity across demographics akin to regional samples studied in projects at University of Colorado Anschutz Medical Campus and include subcohorts for conditions prioritized by consortia such as Alzheimer’s Disease Neuroimaging Initiative and Cancer Genome Atlas. Harmonization of variables leverages standards developed by networks like Observational Health Data Sciences and Informatics and data models exemplified by OMOP Common Data Model.
Specimen types collected include blood, plasma, serum, and DNA, processed in laboratories with workflows comparable to facilities at Mayo Clinic and Broad Institute core labs. Data linkage integrates claims and pharmacy records, laboratory results, and imaging metadata similar to datasets curated by Centers for Medicare & Medicaid Services and repositories following standards from ClinicalTrials.gov. Biorepository operations use logistics approaches modeled on Cold Spring Harbor Laboratory-informed cold chain practices and biobanking standards advocated by International Society for Biological and Environmental Repositories.
Investigations enabled by the Bank span cardiovascular disease, oncology, metabolic disorders, neurodegeneration, and infectious disease research, producing findings in areas studied by groups at American Heart Association, American Cancer Society, Alzheimer’s Association, and Centers for Disease Control and Prevention. Studies have contributed to genomic association analyses that parallel efforts from GIANT Consortium and pharmacogenomic insights akin to those reported by CPIC. Publications leveraging the resource appear in journals such as Nature Genetics, The New England Journal of Medicine, and JAMA-family titles, informing practice guidelines similar to those from U.S. Preventive Services Task Force.
Consent models and privacy protections draw on frameworks from Common Rule revisions and guidance by Office for Human Research Protections, balancing data sharing with confidentiality concerns raised in cases involving HIPAA. Governance incorporates community engagement practices similar to those used in All of Us Research Program and Indigenous data sovereignty discussions exemplified by policies at Havasupai Tribe-related debates. Data access policies parallel controlled access approaches used by dbGaP and institutional data use agreements negotiated with academic partners.
The Bank collaborates with academic centers, public health agencies, and consortia including networks like All of Us Research Program, Million Veteran Program, and regional public health departments in California Department of Public Health-level interactions. Its contributions support surveillance, translational studies, and health equity research informing policy dialogues similar to those involving Centers for Disease Control and Prevention and National Institutes of Health advisory committees. The resource has influenced clinical research capacity at partner institutions including Kaiser Permanente Northern California Division of Research and fostered multi-institutional consortia collaborations.
Category:Biobanks Category:Epidemiological study projects